Implications of Liver-Directed Therapy for Postoperative Hepatic Metastasis from Esophageal Cancer |
Urabe, Masayuki
(Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo)
Yagi, Koichi (Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo) Shiomi, Shinichiro (Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo) Toriumi, Tetsuro (Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo) Okumura, Yasuhiro (Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo) Setoa, Yasuyuki (Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo) |
1 | Liu J, Wei Z, Wang Y, Xia Z, Zhao G. Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma. ANZ J Surg 2018;88:E252-6. DOI |
2 | Pawlik TM, Gleisner AL, Bauer TW, et al. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol 2007;14:2807-16. DOI |
3 | Ichida H, Imamura H, Yoshimoto J, et al. Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma. World J Surg 2013;37:398-407. DOI |
4 | Vega EA, Salehi O, Nicolaescu D, et al. Failure to cure patients with colorectal liver metastases: the impact of the liver surgeon. Ann Surg Oncol 2021;28:7698-706. DOI |
5 | Kurihara T, Itoh S, Kimura Y, et al. Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience. Surg Today 2021;51:1932-7. DOI |
6 | Lou F, Sima CS, Adusumilli PS, et al. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol 2013;8:1558-62. DOI |
7 | Ai D, Zhu H, Ren W, et al. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis 2017;9:3023-30. DOI |
8 | Li H, Zhang S, Guo J, Zhang L. Hepatic metastasis in newly diagnosed esophageal cancer: a population-based study. Front Oncol 2021;11:644860. DOI |
9 | Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016;27:1386-422. DOI |
10 | Yamamoto M, Yoshida M, Furuse J, et al. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. DOI |
11 | Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus 1996;9:173-82. |
12 | Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017. |
13 | Mori K, Aikou S, Yagi K, et al. Technical details of video-assisted transcervical mediastinal dissection for esophageal cancer and its perioperative outcome. Ann Gastroenterol Surg 2017;1:232-7. DOI |
14 | Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45:838-47. DOI |
15 | Tago T, Katsumata K, Udou R, et al. Significance of radiofrequency ablation for unresectable colorectal cancer with liver metastases. Anticancer Res 2021;41:5539-47. DOI |
16 | Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24-31. DOI |
17 | Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 2006;244:524-35. |
18 | Zhang S, Guo J, Zhang H, Li H, Hassan MO, Zhang L. Metastasis pattern and prognosis in men with esophageal cancer patients: a SEER-based study. Medicine (Baltimore) 2021;100:e26496. DOI |
19 | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. DOI |
20 | Park SY, Kim DJ. Esophageal cancer in Korea: epidemiology and treatment patterns. J Chest Surg 2021;54:454-9. DOI |
21 | Shindoh J. Risk stratification and goal of systemic therapy for successful surgical management of colorectal liver metastases: oncological optimization. J Hepatobiliary Pancreat Sci 2021;28:461-9. DOI |
22 | Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus 2019;16:25-43. DOI |
23 | Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13. DOI |
24 | Sugarbaker PH. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer. J Surg Oncol Suppl 1993;3:158-60. DOI |
25 | Ghaly G, Harrison S, Kamel MK, et al. Predictors of survival after treatment of oligometastases after esophagectomy. Ann Thorac Surg 2018;105:357-62. DOI |
26 | Hoffmann K, Bulut S, Tekbas A, Hinz U, Buchler MW, Schemmer P. Is hepatic resection for non-colorectal, non-neuroendocrine liver metastases justified? Ann Surg Oncol 2015;22 Suppl 3:S1083-92. |
27 | Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection. Ann Surg Oncol 2020;27:651-9. DOI |